Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BULK DEALS
Bulk Deals      
Venmax Drugs And Pharmaceuticals Ltd.
BSE Code 531015
ISIN Demat INE154G01022
Book Value -1.27
NSE Code NA
Dividend Yield % 0.00
Market Cap 136.58
P/E 0.00
EPS -0.02
Face Value 10  
 
 
   
Deal DateCompany NameClient NameTranQty.(000's)ValuePriceTrade(Rs.in Lakhs)Close Price
04-Mar-2025 Venmax Drugs&Pharma KAVITA PARIKHBUY 3000019.1257360026.07
04-Mar-2025 Venmax Drugs&Pharma MANASA REDDY DEVIREDDYBUY 4999817.51875464.9826.07
04-Mar-2025 Venmax Drugs&Pharma MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSELL 4515517.51790664.0526.07
04-Mar-2025 Venmax Drugs&Pharma SAMTA POLYMERS LTDBUY 4482017.51784798.226.07
04-Mar-2025 Venmax Drugs&Pharma SANJAY P PARIKHBUY 3000019.3558050026.07
04-Feb-2025 Venmax Drugs&Pharma GREEN PEAKS ENTERPRISES LLPBUY 4765630.881471617.2826.07
03-Feb-2025 Venmax Drugs&Pharma DEEPIKAJINDALBUY 2627629.1764631.626.07
03-Feb-2025 Venmax Drugs&Pharma GREEN PEAKS ENTERPRISES LLPSELL 5900029.1171690026.07
03-Feb-2025 Venmax Drugs&Pharma RIGHT TIME CONSULTANCY SERVICE PRIVATE LIMITEDSELL 3500030.28105980026.07
03-Feb-2025 Venmax Drugs&Pharma SUDHANSHU KANDABUY 5000030.28151400026.07
24-Jan-2025 Venmax Drugs&Pharma MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBUY 3147626.4830966.426.07
10-Jan-2025 Venmax Drugs&Pharma GREEN PEAKS ENTERPRISES LLPBUY 2882121.71625703.9126.07
02-Jan-2025 Venmax Drugs&Pharma SAMTA POLYMERS LTDBUY 4518019.31872425.826.07
30-Dec-2024 Venmax Drugs&Pharma KOMPALLI PRABHAKARSELL 3500017.1960165026.07
24-Dec-2024 Venmax Drugs&Pharma N L RUNGTA (HUF)BUY 500013.466730026.07
24-Dec-2024 Venmax Drugs&Pharma N L RUNGTA (HUF)SELL 4150014.6160631526.07
24-Dec-2024 Venmax Drugs&Pharma VARSHA ACHYUTKUMAR MODISELL 2706714.69397614.2326.07
23-Dec-2024 Venmax Drugs&Pharma MANOJ KUMAR KANDASELL 4000014.1656640026.07
19-Dec-2024 Venmax Drugs&Pharma MANOJ KUMAR KANDABUY 4000012.2749080026.07
19-Dec-2024 Venmax Drugs&Pharma VENKATA RAO SADHANALASELL 17000012.27208590026.07
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.